Martin E. Gutierrez, MD Director, Phase I Program, Co-Chair of Thoracic Oncology, John Theurer Cancer Center and Hackensack Meridian Health shares the standard approach to treating patients who express high levels of PD-L1 in non-squamous, non-small cell lung cancer (NSCLC).
Treating Non-Squamous NSCLC Patients who Express High Levels of PD-L1
